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Introduction
Tuberculosis (TB) represents a major threat for health 
protection in the military forces worldwide [3]. Th e inci-
dence of TB in the military forces is unknown. Military life 
consists in living, training, fi ghting in close quarters [14]. 
Military recruits are deliberately physically and mentally 
stressed during the training [1]. Continuous stress and asso-
ciated harmful habits (e.g. tobacco smoking) could endanger 
the recruit’s healthy state and contribute to the illness de-
velopment [3].  In the United States (U.S.) military popu-
lation’s risk to develop tuberculosis was established eight 
times higher than in the general population [14]. Although, 
the estimated incidence of tuberculosis is unrecognized, the 
late detection and inadequate treatment put the members of 
the military forces at high risk [15]. World Health Organiza-
tion (WHO) recommends stratifying the population accord-
ing to the country specifi c profi le for a better disease control 
[16]. Th e typical risk stratifi cation is based on several crite-
ria diff erentiated in low, mean and high impact risk factors, 
which should be used in the evaluation of each person be-
fore recruiting or each suspected case for tuberculosis [17]. 
Th e major risk factor identifi ed in the (U.S.) military forces 
represents the recruits born in a high tuberculosis burden 
country or immigration from burden regions within 5 years 
from the arrival, and thus their health surveillance is impor-
tant [15]. One of the most important factors associated with 
recrudescence of tuberculosis represents the latent tubercu-
losis infection (LTBI) assessed through the tuberculine skin 
testing (TST). Th e rate of positive TST was established two 
times higher in the American militaries than in the general 
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Abstract
Background: Tuberculosis represents the major threat for the health protection in the military forces. The aim of this retrospective and descriptive study 
was the evaluation of risk factors, clinical presentation and treatment outcomes of tuberculosis in military recruits.
Material and methods: 51 military recruits with tuberculosis diagnosed during 01.01.2010-31.12.2015 in Chisinau military quarters and managed in 
the Hospital of Pneumophtysiology were assessed. 
Results: Most of military recruits aged 18-22, were residents of the rural localities, graduated incomplete general school or lyceum and were economically 
vulnerable. One half of the group consisted of active smokers and every tenth patient abused alcohol. Every fourth patient had tuberculosis in childhood 
and every tenth had family contact with a tuberculosis-affected person. Disease’s insidious onset was established in one half of the group and the acute 
onset in every fourth patient. Every tenth patient was diagnosed with tuberculosis within the first 6 months after the enrollment. Only one half of the 
groups were symptomatic patients, who complained of cough, asthenia and loss of weight. Pulmonary infiltrative tuberculosis predominated among 
recruits. Extensive infiltrates and involvement of both lungs were identified in a lower proportion. The high rate of successful treatment outcome was 
endangered by the high rate of lost to follow-up patients, demonstrating poor evaluation and follow-up after the discharging from the hospital.
Conclusions: The epidemiological studies among military recruits are limited. The high rate of young, economically vulnerable men with risk factors 
demonstrates their priority for active screening. Treatment outcomes must be improved by the implementation of the adequate follow-up after hospital 
discharging.
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population and higher in the American naval forces than in 
the army and air forces [14]. For improving the LTBI diag-
nosis there were recommended several commercially avail-
able interferon-gamma releasing assays (IGRAs): QuantiF-
ERON-TB Gold and T-Spot TB test. However, the high rate 
of false-positive IGRAs results limits the usefulness in the 
LTBI and disease diagnosis [5, 20]. Other high risk factor 
for tuberculosis in military personnel is the HIV-infection 
or other immunocompromising conditions. According to 
the Moldovan national regulation the candidates for the in-
corporation in the military service should be investigated 
by clinical (physical examination) and laboratory methods 
during the health expertise performed by the medical mili-
tary commission (MMC) [12]. Th e tuberculosis screening 
in military personnel is standardised and consists in medi-
cal history, physical examination and chest radiography [8, 
12]. Th e capacity to perform military service is given by the 
excluding of well specifi ed chronic diseases: HIV-infection, 
tuberculosis, diabetes, conditions requiring long-lasting im-
mune suppressive treatment, cardiac diseases, arterial hy-
pertension, renal diseases, central and peripheral nervous 
system diseases, psychiatric disorders, gastrointestinal dis-
orders (chronic hepatitis, chronic malabsorption syndrome, 
chronic pancreatitis), low body weight and injection drug 
use [12]. Comparing the regulation papers, in the U.S. the 
militaries are investigated annually and are asked to answer 
some questions about: a) the face-to-face contact with some-
one sick with tuberculosis, b) place of birth and the presence 
of the family members outside the U.S., c) if the person had 
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losis, d) if the persons worked or lived in a detainee facility, 
prison, homeless shelter, refugee camp or drug treatment fa-
cility, d) if the persons had an organ transplant, requires im-
munosuppressive medication (immune modulators or pred-
nisone), had cancer of the head and neck, Hodgkin’s disease, 
leukemia, end-stage renal disease, intestinal by-pass or gas-
trectomy [15].  A major attention is paid to the disease con-
trol among U.S. military health care workers. Th e U.S. health 
care workers caring the militaries are compulsory investigat-
ed if they: a) have the following symptoms: cough more than 
2 weeks, fever more than 2 weeks, night sweats and weight 
loss; b) were working in an emergency room, inpatient hos-
pital settings, mycobacteriology laboratory or other settings 
where tuberculosis patients are investigated and treated; c) 
had face-to-face contact with a sick person with tuberculosis 
and d) had written documentation of a prior positive TST, 
tuberculosis diagnosis and treatment [15]. 
Standard methods are used worldwide to detect tubercu-
losis in military population. Acid-fast bacilli sputum smear 
staining and culture on the conventional liquid or solid me-
dia are performed to each suspected person. Th is requires 
collecting at least two sputum samples in 8-24 hour intervals 
and one of which should be an early morning specimen [11]. 
However, the poor sensitivity (<30% in MD, <50% in the 
U.S.) of smear staining and delay of culture results (requires 
at least 120 days for providing a positive result) endanger 
the disease control in a military population [17]. Close con-
tact between military personnel and their high receptivity to 
the infection make compulsory the performing the nucleic 
acid amplifi cation testing in the frame of the case investi-
gation. GeneXpert MTB/Rifampicine (Cepheid, California) 
represents a method extremely useful with a rapid capacity 
(2 hours) to detect Mycobacterium DNA and Rifampicin re-
sistance mutations of the rpoB gene. It plays a decisive role in 
the treatment, allowing the onset of the treatment for multi-
drug-resistant infection before the results of the drug sensi-
tivity test are available [7]. Th e U.S. Centre for Disease Con-
trol (CDC) recommends the use of IGRAs and TST for LTBI 
diagnosis. However, CDC requires that the results should be 
evaluated according to the patient’s risk factors for infection 
and for developing the active disease. In the U.S. military set-
tings several epidemics of TST conversions (prior negative 
than positive TST) were reported, but were attributed to the 
errors in the administration and reading of TST and cross-
reactivity with non-tuberculosis mycobacteria [14].
Th e WHO’s guideline for the treatment of tuberculosis is 
strongly recommended to be used in the settings caring sick 
military personnel [15]. Th e treatment must be performed 
as directly observed therapy (DOT) only in health care set-
tings and the sick military person should be isolated until 
they have met the following criteria: 1) treatment with an 
eff ective regimen for at least 2 weeks; 2) two negative spu-
tum smear at the end of the treatment’s intensive phase; 
3) clinical improvement during the treatment. Th e sick mili-
tary personnel should be isolated in a negative pressured 
room and all infection control measures used [6, 15, 18]. 
Th e standard treatment for new patients presumed or 
known to have drug-susceptible tuberculosis is performed 
since 1993 and lasts 6 months [18]. It consists in a two phase 
regimen with four fi rst-line drugs: isoniazid (H), rifampicine 
(R), ethambutol (E) and pyrazinamide (Z) used in the inten-
sive phase and two fi rst-line drugs: isoniazid and rifampicine 
used in the continuation phase. Previously sick patients have 
to be treated during 8 months with the same two phase regi-
men consisted of fi ve fi rst-line drugs: H, R, E, Z and strepto-
mycine (S) in the intensive phase for 3 months followed by 
the continuation phase with H, R and E during the next 5 
months. One of the emerging challenges in the treatment of 
tuberculosis in military forces is the epidemic extension of 
drug-resistance strains of Mycobacterium. Multidrug-resis-
tant tuberculosis (MDR-TB) means the resistance to at least 
two of the most powerful fi rst-line bactericidal drugs: iso-
niazid and rifampicine. An associated resistance to second-
line drugs such as aminoglicozides (amikacyne, kanamycin 
and capreomycine) and any fl uoroquinolone (levofl oxacine 
or moxifl oxacine) associated with multidrug-resistance was 
called extensively drug-resistant tuberculosis [22]. Military 
members are at a greater risk to become infected with drug-
resistant strains circulating within the outbreaks from the 
quarters, but higher during the military service or overseas 
travel in the TB-endemic countries [10]. Usually patients 
identifi ed with rifampicine-resistant strains or MDR-TB are 
treated with the standard combination of the second-line 
drugs for 18- 24 months (DOTS-Plus regimen) or diff er-
ent combinations (individualized regimens). Th e MDR-TB 
treatment success rate is low. It is associated with signifi cant 
adverse events and poor treatment compliance [22]. In the 
Republic of Moldova the anti-tuberculosis treatment in mili-
tary personnel is performed in specialized clinical depart-
ments during the intensive phase and in ambulatory at the 
home residence conditions in the continuous phase [4].
Reviewing exposed information it can be proved that tu-
berculosis, as a communicable, infectious disease is endan-
gering the health protection in military forces all over the 
world. Th e rate of tuberculosis among millitary personnel 
is unknown, but the risk of infection and disease develop-
ing is much higher than in the general population. Reactiva-
tion of the latent tuberculous infection represents one of the 
most important factors for tuberculosis development in for-
eign born or immigrated persons from endemic countries; 
however, infection with drug-resistant strains is higher in 
outbreaks and during overseas military service. Case-man-
agement could be improved by performing cohort investiga-
tions, education of the military population about the clini-
cal signs, detection procedures and using molecular genetic 
assays in all suspected cases. Treatment outcome could be 
improved by implementing an adequate patient’s follow-up 
and evaluation.
Th e aim of the study was the assessment of the risk fac-
tors, clinical presentation and treatment outcome of tuber-
culosis in military recruits. Th e established objectives were: 
1. assessment of social, economical and epidemiological risk 
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factors for tuberculosis in military recruits; 2. evaluation of 
the case-management, clinical and radiological aspects, mi-
crobiological results and treatment outcomes in military re-
cruits.
Material and methods
According to the regulatory documents the military ser-
vice of the Moldovan citizens in the National Armed Forces 
is performed in the frame of the National Army and Cara-
bineer Troops during a limited period of time. Th e military 
service is performed compulsory by the citizens enlisted 
into the military service in term during 3 months (short 
contract), one year or more as specifi ed time in the contract 
(variable contract).
It was performed a retrospective selective, descriptive 
study targeting risk factors, clinical aspects, laboratory re-
sults and treatment outcome of 51 patients – military re-
cruits from the Chisinau Carabineer Troops diagnosed with 
tuberculosis in the period 01.01.2010-31.1201.2015. Th e in-
clusion criteria were: young age (18-24 years old) and signed 
informed consent. Th e study schedule included demo-
graphic, social, economical and epidemiological data, clini-
cal features and laboratory results. All selected patients were 
diagnosed and managed according to the National Clinical 
Protocol 123 “Tuberculosis in adults”.  Statistic assessment 
was carried out using the quantitative and qualitative re-
search methods. Statistical survey was performed using Mi-
crosoft  Excel XP soft .
Results and discussion
All patients enrolled in the study were men. When 
distributing patients in age groups was established that 
the youngest group (18-20 years old) was the largest – 45 
(88.23%) patients. Assessing the patients’ residence was es-
tablished that most of them were from the rural localities of 
the republic– 46 (90.19%) cases. No homeless patients were 
identifi ed among selected cases. Distributing patients ac-
cording to the educational level, it was determined that low 
level of school education (incomplete secondary school) was 
identifi ed in every fourth case (13 (25.49%) patients), gradu-
ated lyceum one half of the group [25 (49.02%) patients], 
professional or superior studies had 9 (17.64%) patients. 
Distributing patients according to the economical status 
it was established that the rate of employed patients before 
the recruitment was very low [4 (7.84%) patients]. History 
of migration in the last year was established in 2 (3.92%) pa-
tients. Every third patient [38 (74.51%) patients] was living 
under the standard of minimum consumption basket. As-
sessing the marital status it was identifi ed that the major-
ity of the patients [47 (92.16%) patients] were single-state 
persons due to their young age. Harmful social habits such 
as active tobacco smoking was established in one half of the 
group (25 (49,02%) patients) and alcohol abusers were 6 
(11.76%) patients. No drug users were identifi ed.
Th e proportion of patients with epidemiologic risk fac-
tors was low. Only 8 (15.68%) patients were from family 
infectious clusters, among them, 4 (7.84%) patients were 
in contact with drug-resistant tuberculosis family mem-
bers and 3 (5.88%) patients were from clusters where a dead 
person due to tuberculosis was registered. Were previously 
treated for tuberculosis 12 (23.53%) patients and were diag-
nosed with post-tuberculosis lung changes 2 (3.92%) cases. 
Th e rate of uninsured patients before recruitment was 
high [47 (92.16%) cases]. Diagnosis of tuberculosis was 
delayed for more than 60 days from the onset of the symp-
toms in 22 (43.14%) cases. Acute onset of tuberculosis was 
identifi ed in 14 (27.45%) patients. 27 (52.97%) patients 
complained of the symptoms of the intoxication syndrome. 
Asthenia and loss of weight were identifi ed in 27 (52.97%) 
patients, night sweats in 25 (49.02%) cases, fever in 4 (7.84%) 
cases, headache in 4 (7.84%) cases, loss of consciousness in 
2 (3.92%) cases. Bronchopulmonary signs were established 
in 28 (54.91%) cases: cough for more than 3 weeks in 28 
(45.91%) cases, thoracic pain in 5 (9.81%) cases, dysphagia 
in 2 (3.92%) cases and heamopthysis in 1 (1.96%) case. As-
sociated diseases were diagnosed in 3 (5.88%) patients. No 
HIV infection, diabetes, immunosuppressive treatment and 
psychiatric disorders were identifi ed. 
Within the fi rst 3 months aft er the enrollment 10 
(19.61%) recruits developed tuberculosis and aft er the next 
three months – 16 (31.37%) recruits. During the fi rst three 
months of the second semester 12 (23.53%) recruits devel-
oped active tuberculosis and three months later – 25.49%) 
patients (fi g. ).
Fig. 1.  Duration between enrollment and disease 
diagnosis (%).
Th e large spectrum antibiotherapy was initiated before 
tuberculosis treatment in 11 (21.57%) patients. When as-
sessing the high risk factors, their hierarchy was established: 
patient’s rural residence, unemployment before recruiting 
and harmful habits. Th e epidemiological risk factors such as 
household tuberculous contact and history of recent migra-
tion were identifi ed in a low proportion, but it is important 
to emphasize the role of such factors in the infection and 
disease progression. Patients with comorbidities were in a 
limited number due to clear prohibiting conditions for the 
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Fig. 2.  Distribution of military recruits in risk groups (%).
Evaluating the laboratory features of the selected pa-
tients it was identifi ed that 9 (17.64%) patients had positive 
results at the microscopic testing for acid-fast-bacilli and 8 
(15.67%) had positive culture on solid Lowenstein-Jensen 
or liquid media (MGIT BACTEC). Th e fi rst-line anti-tuber-
culosis drugs susceptibility was established in 6 (11.76%) 
cases, mono-resistance in 2 (3.92%) cases and multidrug-
resistance in 1 (1.96%) case.
When assessing the radiological features of selected pa-
tients it was established that the patients with one aff ected 
lung outnumbered those with both involved lungs [38 
(74.51%) vs. 13 (25.49%) cases, p<0,001]. Right superior lobe 
was aff ected in 21 (41.18%) cases and left  superior lobe in 14 
(27.45%) cases. Tuberculosis of the right lung was diagnosed 
more frequently than in the left  lung: 29 (56.86%) patients 
compared to 22 (43.14) patients. Extensive infi ltrates involv-
ing more than 3 segments were established in 12 (23.53%) 
cases and lung destruction was identifi ed in 9 (17.64%) 
cases. Th e greatest part of the group was diagnosed with 
infi ltrative form of pulmonary tuberculosis – 43 (84.31%) 
patients. Limited forms, recognized as nodular tuberculosis 
were diagnosed in 5 (9.81%) cases. It is important to note the 
absence of cases with severe forms, such as disseminated or 
fi bro-cavernous tuberculosis. Secondary localizations were 
diagnosed in a low proportion: pleurisy – 3 (5.88%) patients 
and tuberculosis of the bronchus – 2 (3.92%) patients. Ex-
trapulmonary form, such as tuberculosis of intrathoracic 
lymph nodes was diagnosed in 2 (3.92%) patients. Data were 
revealed in the fi gures 3 and 4.
Fig. 3.  Established clinical diagnosis in military recruits (%).
Comparing obtained results with previously published 
studies in the national journals it can be demonstrated that 
pulmonary tuberculosis was established in a similar rate as 
in the general population [9]. However, the rate of extensive 
infi ltrates associating lung destruction and involvement of 
both lungs was much lower than in the general population.
Fig. 4.  Radiological features of pulmonary tuberculosis in 
military recruits (%).
As a consequence the proportion of positive microbio-
logical results, which included smear microscopy and cul-
ture in the conventional media, was very low (fi g. 4).
Fig. 5.  The proportion of microbiological positive results.
All patients were treated during the intensive phase in 
the Chisinau Municipal Hospital of Pneumophtysiology. 
One half of the group [25 (49.02%) patients] was hospital-
ized for 2 months in the Municipal Hospital of Tuberculosis, 
7 (13.72%) patients were hospitalized on average 3 months 
and 19 (37.25%) patients – more than 3 months. Treatment 
for MDR-TB was performed in 3 (5.88%) patients. Success-
fully treated according to the national policy criteria were 
41 (80.39%) patients, that included 18 (35.29%) cured and 
23 (45.10%) with completed treatment, 9 (17.64%) were lost 
to follow-up and 1 (1.96%) patient failed the treatment.  Th e 
follow-up till 2016 of the selected group identifi ed that 14 
(27.46%) patients were included in retreatment regimens 
(fi g. 3).
Fig. 6.  Final treatment outcomes (%).
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Conclusions
Moldovan citizens perform military service in the Na-
tional Army or Carabineer Troops during diff erent periods, 
specifi ed in the contract.
In the Chisinau Municipal Clinical Hospital were diag-
nosed and treated 51 military recruits in the period 2010-
2015. 
All were men. Most of them were aged between 18-22 
years old and were from rural localities of the republic.  Ev-
ery fourth had low level of the school degree and one half 
graduated the lyceum.
Before recruiting most of the patients had an economi-
cal vulnerable state, lacked the health insurance and were 
single-state persons. Obtained results demonstrated that 
military recruits had low accessibility to health care services 
due to their social vulnerability.
One half of the group comprised active smokers.  Every 
fourth patient had tuberculosis in the childhood. Family 
contact with a sick person and the history of migration were 
established in a small number of cases.
Disease’s insidious onset was established in one half of 
the group and acute onset in every fourth patient. Every 
tenth patient was diagnosed with tuberculosis within the 
fi rst 6 months aft er the enrollment in the military service.
Cough, asthenia and loss of weight were established in all 
symptomatic cases, which constitute one half of the group.
Pulmonary forms of tuberculosis were the most preva-
lent, although extrapulmonary forms as pleurisy and tuber-
culosis of intrathoracic lymph nodes were diagnosed as well. 
Extensive infi ltrates and involvement of both lungs were 
identifi ed in a lower proportion than in the general popula-
tion. No severe forms were diagnosed. Comorbidities were 
diagnosed in a limited number of cases at the same time with 
tuberculosis.
High rate of successfully treated militaries was endan-
gered by a high rate of the lost to follow-up patients, demon-
strating poor control aft er the discharging from the hospital 
and the military service.
Th e epidemiological data on tuberculosis among Mol-
dovan military forces is unknown. Th e high rate of young, 
economically vulnerable men with risk factors demonstrates 
their priority for active screening. 
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